Analysis of mortality metrics associated with a comprehensive range of disorders in Denmark, 2000 to 2018: A population-based cohort study.
Journal
PLoS medicine
ISSN: 1549-1676
Titre abrégé: PLoS Med
Pays: United States
ID NLM: 101231360
Informations de publication
Date de publication:
06 2022
06 2022
Historique:
received:
13
12
2021
accepted:
17
05
2022
entrez:
16
6
2022
pubmed:
17
6
2022
medline:
22
6
2022
Statut:
epublish
Résumé
The provision of different types of mortality metrics (e.g., mortality rate ratios [MRRs] and life expectancy) allows the research community to access a more informative set of health metrics. The aim of this study was to provide a panel of mortality metrics associated with a comprehensive range of disorders and to design a web page to visualize all results. In a population-based cohort of all 7,378,598 persons living in Denmark at some point between 2000 and 2018, we identified individuals diagnosed at hospitals with 1,803 specific categories of disorders through the International Classification of Diseases-10th Revision (ICD-10) in the National Patient Register. Information on date and cause of death was obtained from the Registry of Causes of Death. For each of the disorders, a panel of epidemiological and mortality metrics was estimated, including incidence rates, age-of-onset distributions, MRRs, and differences in life expectancy (estimated as life years lost [LYLs]). Additionally, we examined models that adjusted for measures of air pollution to explore potential associations with MRRs. We focus on 39 general medical conditions to simplify the presentation of results, which cover 10 broad categories: circulatory, endocrine, pulmonary, gastrointestinal, urogenital, musculoskeletal, hematologic, mental, and neurologic conditions and cancer. A total of 3,676,694 males and 3,701,904 females were followed up for 101.7 million person-years. During the 19-year follow-up period, 1,034,273 persons (14.0%) died. For 37 of the 39 selected medical conditions, mortality rates were larger and life expectancy shorter compared to the Danish general population. For these 37 disorders, MRRs ranged from 1.09 (95% confidence interval [CI]: 1.09 to 1.10) for vision problems to 7.85 (7.77 to 7.93) for chronic liver disease, while LYLs ranged from 0.31 (0.14 to 0.47) years (approximately 16 weeks) for allergy to 17.05 (16.95 to 17.15) years for chronic liver disease. Adjustment for air pollution had very little impact on the estimates; however, a limitation of the study is the possibility that the association between the different disorders and mortality could be explained by other underlying factors associated with both the disorder and mortality. In this study, we show estimates of incidence, age of onset, age of death, and mortality metrics (both MRRs and LYLs) for a comprehensive range of disorders. The interactive data visualization site (https://nbepi.com/atlas) allows more fine-grained analysis of the link between a range of disorders and key mortality estimates.
Sections du résumé
BACKGROUND
The provision of different types of mortality metrics (e.g., mortality rate ratios [MRRs] and life expectancy) allows the research community to access a more informative set of health metrics. The aim of this study was to provide a panel of mortality metrics associated with a comprehensive range of disorders and to design a web page to visualize all results.
METHODS AND FINDINGS
In a population-based cohort of all 7,378,598 persons living in Denmark at some point between 2000 and 2018, we identified individuals diagnosed at hospitals with 1,803 specific categories of disorders through the International Classification of Diseases-10th Revision (ICD-10) in the National Patient Register. Information on date and cause of death was obtained from the Registry of Causes of Death. For each of the disorders, a panel of epidemiological and mortality metrics was estimated, including incidence rates, age-of-onset distributions, MRRs, and differences in life expectancy (estimated as life years lost [LYLs]). Additionally, we examined models that adjusted for measures of air pollution to explore potential associations with MRRs. We focus on 39 general medical conditions to simplify the presentation of results, which cover 10 broad categories: circulatory, endocrine, pulmonary, gastrointestinal, urogenital, musculoskeletal, hematologic, mental, and neurologic conditions and cancer. A total of 3,676,694 males and 3,701,904 females were followed up for 101.7 million person-years. During the 19-year follow-up period, 1,034,273 persons (14.0%) died. For 37 of the 39 selected medical conditions, mortality rates were larger and life expectancy shorter compared to the Danish general population. For these 37 disorders, MRRs ranged from 1.09 (95% confidence interval [CI]: 1.09 to 1.10) for vision problems to 7.85 (7.77 to 7.93) for chronic liver disease, while LYLs ranged from 0.31 (0.14 to 0.47) years (approximately 16 weeks) for allergy to 17.05 (16.95 to 17.15) years for chronic liver disease. Adjustment for air pollution had very little impact on the estimates; however, a limitation of the study is the possibility that the association between the different disorders and mortality could be explained by other underlying factors associated with both the disorder and mortality.
CONCLUSIONS
In this study, we show estimates of incidence, age of onset, age of death, and mortality metrics (both MRRs and LYLs) for a comprehensive range of disorders. The interactive data visualization site (https://nbepi.com/atlas) allows more fine-grained analysis of the link between a range of disorders and key mortality estimates.
Identifiants
pubmed: 35709252
doi: 10.1371/journal.pmed.1004023
pii: PMEDICINE-D-21-05097
pmc: PMC9202944
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1004023Déclaration de conflit d'intérêts
I have read the journal’s policy and the authors of this manuscript have the following competing interests: JWD has been involved in projects funded by the Novo Nordisk Foundation (NNF16OC0019126), The Central Denmark Region, and the Danish Epilepsy Association during the conduct of this study.
Références
Am J Epidemiol. 2016 Aug 1;184(3):199-210
pubmed: 27407085
Stat Med. 2017 Sep 30;36(22):3573-3582
pubmed: 28585255
Stat Med. 2013 Dec 30;32(30):5278-85
pubmed: 23839860
Forensic Sci Int. 2014 Nov;244:289-94
pubmed: 25300069
Eur Heart J. 2015 Jan 7;36(2):83-93b
pubmed: 25492627
Schizophr Res. 2019 Apr;206:284-290
pubmed: 30446270
Lancet. 2016 Oct 8;388(10053):1813-1850
pubmed: 27665228
Scand J Public Health. 2011 Jul;39(7 Suppl):54-7
pubmed: 21775352
Scand J Public Health. 2011 Jul;39(7 Suppl):30-3
pubmed: 21775347
PLoS One. 2013;8(1):e55176
pubmed: 23372832
Scand J Public Health. 2011 Jul;39(7 Suppl):26-9
pubmed: 21775346
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326
Lancet Psychiatry. 2017 Dec;4(12):937-945
pubmed: 29122573
Lancet. 2019 Nov 16;394(10211):1827-1835
pubmed: 31668728
World Psychiatry. 2020 Oct;19(3):339-349
pubmed: 32931098
Br J Psychiatry. 2011 Dec;199(6):441-2
pubmed: 22130744
EClinicalMedicine. 2020 Nov 01;28:100605
pubmed: 33163948
N Engl J Med. 2020 Apr 30;382(18):1721-1731
pubmed: 32348643
JAMA. 2015 Jan 6;313(1):37-44
pubmed: 25562264
BMJ. 2013 May 21;346:f2539
pubmed: 23694688
Lancet. 2020 Oct 17;396(10258):1223-1249
pubmed: 33069327
Environ Health Perspect. 2014 Sep;122(9):906-11
pubmed: 24911630
PLoS One. 2020 Mar 6;15(3):e0228073
pubmed: 32142521
BMC Cancer. 2015 May 17;15:412
pubmed: 25982368
JAMA Netw Open. 2020 Jun 1;3(6):e206646
pubmed: 32492163
Scand J Public Health. 2011 Jul;39(7 Suppl):22-5
pubmed: 21775345
Nat Commun. 2020 Oct 2;11(1):4952
pubmed: 33009368